A recent 3D mapping of human tau pathology suggests, for instance, a more widespread distribution of NFT at the early stages of Alzheimer’s disease: similar levels of tau burden were found in entorhinal areas and the amygdala, the hippocampus, and the temporopolar cortex, supporting our MRI findings.26 The gene discussed is MAPT; the disease is Alzheimer disease.